Amalia Capilla
AeroLeads people directory · profile

Amalia Capilla Email & Phone Number

CEO Miramoon Pharma at Miramoon Pharma
Location: San Sebastián, Basque Country, Spain 15 work roles 3 schools
1 work email found @sigilon.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email a****@sigilon.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
CEO Miramoon Pharma
Location
San Sebastián, Basque Country, Spain

Who is Amalia Capilla? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Amalia Capilla is listed as CEO Miramoon Pharma at Miramoon Pharma, based in San Sebastián, Basque Country, Spain. AeroLeads shows a work email signal at sigilon.com and a matched LinkedIn profile for Amalia Capilla.

Amalia Capilla previously worked as Chief Executive Officer at Miramoon Pharma and Co-Founder at Plaia Technologies. Amalia Capilla holds Phd Degree In Molecular Biology, Biological Sciences, Summa Cum Laude from Universidad De Valencia.

Company email context

Email format at Miramoon Pharma

This section adds company-level context without repeating Amalia Capilla's masked contact details.

{first}.{last}@sigilon.com
86% confidence

AeroLeads found 1 current-domain work email signal for Amalia Capilla. Compare company email patterns before reaching out.

Profile bio

About Amalia Capilla

Amalia Capilla is a CEO Miramoon Pharma at Miramoon Pharma. She possess expertise in biotechnology, biochemistry, molecular biology, cell culture, pcr and 19 more skills. She is proficient in English.

Listed skills include Biotechnology, Biochemistry, Molecular Biology, Cell Culture, and 20 others.

Current workplace

Amalia Capilla's current company

Company context helps verify the profile and gives searchers a useful next step.

Miramoon Pharma
Miramoon Pharma
CEO Miramoon Pharma
AeroLeads page
15 roles

Amalia Capilla work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer

Current

San Sebastián, Basque Country, Spain

Aug 2024 - Present

Head Of Operations

Tyris Tx

By combining our pioneering oDNA™ with exclusive innovative Non-Viral vector delivery, we are progressing re-dosable gene therapies with drug titration capabilities and targeted biodistribution, whatever the size of the gene involved

Apr 2022 - Mar 2023

Director Of Diabetes Cell Therapy

Sigilon Therapeutics, Inc.
Jul 2021 - Apr 2022

Principal Scientist

Sigilon Therapeutics, Inc.
Jul 2020 - Jul 2021

Senior Scientist

Sigilon Therapeutics, Inc.

Cambridge, Massachusetts

Sep 2018 - Jul 2020

Postdoctoral Researcher

Boston University School Of Medicine. Center For Regenerative Medicine

Boston, MA

Generation of human intestinal organoids from human iPSC ( induced pluripotent stem cells) to model hereditary forms of colorectal cancer such as FAP and Lynch Syndrome, and IBD.

Sep 2015 - Jun 2018

Postdoctoral Researcher

Section Of Cell And Developmental Biology. Prof. Mcginnis

Role of innate immunity (Toll/NFkB pathway) in wound healing and re-epithelialization in Drosophila melanogaster as model organism

Nov 2013 - Nov 2014

Postdoctoral Researcher

Instituto De Biomedicina De Valencia. Developmental Cell Biology. Dr. Galindo

Regulation of Planar Cell Polarity and Notch signaling pathways in Drosophila leg development

Jun 2010 - Dec 2012

Phd Student

Instituto De Biomedicina De Valencia. Genetics And Molecular Medicine. Dr. Palau

Head of the genetic study in PROFICEL, a coordinated project from Genetics, Immunology and Microbiology laboratories of the Spanish National Research Council to perform an extensive study of Celiac Disease (CD)

Feb 2006 - Jun 2010

Masters Student

Pediatric Gastroenterology Unit. Dra. Ribes-Koninckx

Genetic and functional analysis of non-HLA genes associated to celiac disease

Feb 2003 - Feb 2006

Collaborator Student

Biochemistry And Molecular Biology Department. Dr. Costell

Distribution of Perlecan in the eye. Consequences of the lack of protein in retina development

Apr 2000 - Nov 2002
3 education records

Amalia Capilla education

M. Sc., Biochemistry And Clinical Immunology, Biochemistry And Immunology

Facultad De Medicina. Universitat De València
FAQ

Frequently asked questions about Amalia Capilla

Quick answers generated from the profile data available on this page.

What company does Amalia Capilla work for?

Amalia Capilla works for Miramoon Pharma.

What is Amalia Capilla's role at Miramoon Pharma?

Amalia Capilla is listed as CEO Miramoon Pharma at Miramoon Pharma.

What is Amalia Capilla's email address?

AeroLeads has found 1 work email signal at @sigilon.com for Amalia Capilla at Miramoon Pharma.

Where is Amalia Capilla based?

Amalia Capilla is based in San Sebastián, Basque Country, Spain while working with Miramoon Pharma.

What companies has Amalia Capilla worked for?

Amalia Capilla has worked for Miramoon Pharma, Plaia Technologies, Epidisease Sl, Tyris Tx, and Sigilon Therapeutics, Inc..

How can I contact Amalia Capilla?

You can use AeroLeads to view verified contact signals for Amalia Capilla at Miramoon Pharma, including work email, phone, and LinkedIn data when available.

What schools did Amalia Capilla attend?

Amalia Capilla holds Phd Degree In Molecular Biology, Biological Sciences, Summa Cum Laude from Universidad De Valencia.

What skills is Amalia Capilla known for?

Amalia Capilla is listed with skills including Biotechnology, Biochemistry, Molecular Biology, Cell Culture, Pcr, Research, Microbiology, and Drosophila.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.

People with similar names

Check these profiles if this is not the Amalia Capilla you were looking for.

View similar profiles